| Category of Drug | Strontium Ranelate is a drug in Osteoporosis |
| Mechanism of Action | |
| Indications | Strontium Ranelate is used 1. To reduce the risk of fractures in postmenopausal osteoporosis |
| Well Known Pharmaceutical Brands | |
| Available dosage forms | Granules |
| Dose | |
| Contraindications | 1. Hypersensitivity 2. Phenylketonuria 3. Severe renal impairment 4. Patients at increased risk of venous thromboembolism |
| Precautions | 1. Pregnancy 2. Lactation 3. Children and the elderly 4. Interactions |
| Adverse Effects | 1. Nausea and diarrhoea 2. Headache 3. Eczema 4. A transient reversible increase in creatine kinase activity 5. Memory loss on long term use 6.Venous thromboembolism 7. Dermatitis |
| Pregnancy Category |
